Cargando…
The role of TLR8 signaling in Acute Myeloid Leukemia Differentiation
Acute myeloid leukemia (AML) is an aggressive disease with a poor 5-year survival of 21% that is characterized by a differentiation arrest of immature myeloid cells. For a rare subtype of AML (acute promyeloctyic leukemia, 5-10% of cases) all-trans retinoic acid therapy removes the differentiation b...
Autores principales: | Ignatz-Hoover, James J, Wang, Huaiyu, Moreton, Stephen A, Chakrabarti, Amit, Agarwal, Mukesh K, Sun, Kevin, Gupta, Kalpana, Wald, David N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387126/ https://www.ncbi.nlm.nih.gov/pubmed/25283842 http://dx.doi.org/10.1038/leu.2014.293 |
Ejemplares similares
-
Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML
por: Gupta, Kalpana, et al.
Publicado: (2011) -
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
por: Ueda, Masumi, et al.
Publicado: (2020) -
Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients
por: Aref, Salah, et al.
Publicado: (2020) -
Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
por: Ramzi, Mani, et al.
Publicado: (2018) -
Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways
por: Coveney, Andrew P., et al.
Publicado: (2015)